Texas Heart Institute Home
Continuing Medical Education
 
CME Home
 

To participate in this event:
1. Read CME information.
2. View course materials.
3. Complete assessment. 
4. Obtain CME credit.

 
Cardiology Grand Rounds

Cardiac BioInterventions: Gene Therapy and Cellular Reprogramming - Has the Day Finally Come?   

Date of Online Release: October 11, 2013
Date of Original Grand Rounds: September 20, 2013
Credits: .75 AMA PRA Category 1 Credit™
See link to Course Materials below.


CME Information - Overview

 
This presenter will review how cardiac cellular reprogramming and cardiac angiogenic gene therapy represent potential biologic means of treating heart failures and ischemia.

Educational Objectives
The intended result of this activity is increased knowledge. At the conclusion of this presentation, participants should be able to-

  • Describe potential for cardiac cellular reprogramming.
  • Associate with the status of clinical trials in the field.
  • Discuss reasons for delays in approval and clinical advancement of cardiac gene therapy treatment options. 

Target Audience
The intended audience for this continuing medical education activity includes cardiologists, surgeons, internists, and researchers.

Method of Instruction / Participation
This online enduring material comprises slide sets with text and audio derived from a live cardiology grand rounds presentation with post activity assessment and evaluation.

Evaluation / Feedback
We value your feedback; please send your suggestions and comments to the Office of Continuing Medical Education at Texas Heart Institute, cme@texasheart.org.

Speaker

   
Dr. Todd K. Rosengart





Todd Rosengart, MD
Chairman & Professor,
Surgery 
Baylor College of Medicine
Houston, Texas    


 

Accreditation / Credit Designation 

Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Texas Heart Institute designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Estimated Study Time
The estimated time to complete this activity, including review of the materials and completion of the course assessment is 45 minutes.

Repurposing Statement
If you previously completed and received credit for the live CME-sponsored grand rounds entitled, Cardiac BioInterventions: Gene Therapy and Cellular Reprogramming-Has the Day Finally Come? on September 20, 2013, please note that you will not receive credit for completing this activity. Participants who take part in an identical activity, even in order to validate learning or to clarify specific topics, cannot claim, nor will the Texas Heart Institute award, duplicate credit for the activity.

Term of Approval  
October 11, 2013 through October 11, 2016. Continuation of CME credit from October 11, 2016 depends on a thorough review of the content for currency and accuracy.

Peer Review
In September 2013, this continuing medical education activity was reviewed for currency and accuracy of content by Patrick J. Hogan, MD, FACC, Director, Learning Resource Center and Co-Chairman, Medical Education Committee—Texas Heart Institute, Houston, Texas. Dr. Hogan does not have any disclosures relevant to this program.

Disclosure of Relationships
It is the intent of the Texas Heart Institute to ensure that its educational mission and its continuing medical activities in particular, should not be influenced by the special interests of individuals associated with its program.

Faculty Disclosure
In accordance with the guidelines of the Accreditation Council for Continuing Medical Education, everyone in a position to control content (faculty, planners, reviewers, others who control content including their spouse/partner) has disclosed to Texas Heart Institute their relevant financial relationships with commercial interests. The Institute defines "relevant financial relationships" as financial relationships of the individual (including those of the individual's spouse or partner) in any amount occurring within the past 12 months that create a conflict of interest. The ACCME defines "commercial interest" as any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients.

Dr. Rosengart does not have any disclosures relevant to this program.

The Planning Committee has nothing to disclose.
The THI CME Staff have nothing to disclose.
The Program Reviewers have nothing to disclose.

Course Materials and CME Credit 

This online enduring material comprises one presentation. By clicking on the course materials link, you acknowledge that you have reviewed the CME information provided above. After viewing the presentation, you must complete an assessment and evaluation to obtain CME credit for this activity.

Course Materials

Return to Explore Grand Rounds.
 
Find Us on Facebook!

Please contact our Webmaster with questions or comments.
Terms of Use and Privacy Policy
© Copyright Texas Heart Institute. All rights reserved.
Texas Heart Institute, Texas Heart, Texas Heart Institute Journal, THI, Heart Owner's, Leading With the Heart and Heart of Discovery are members of the
family of trademarks of the Texas Heart Institute.


U.S. NEWS America's Best Hospitals 2012-13